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ABSTRACT 
The primary objective of this research was to identify and address the factors 
involved in overall quality production of ER Pharmaceutical products. A second 
objective was to be operationlise. These factors with the system, "cetirus parebus" that 
enable a company to shift from one with lower level of quality skills to one that would be 
in line with the call of "Quality 2020". As expected the two factors come to the fore: - a) 
quality products b) the ability to use quality to meet the needs and satisfaction of 
customers. 
Internal and external customers were assessed by Analytical Hierarchy Process 
Survey techniques to assess the needs and identify factors in this study. Questionnaires 
were issued and return monitored. The two objectives was to collect data as integrated 
factors of Product Quality and Human Resources factors involved in Human Resources 
related to product quality. There were thirteen product quality factors selected for this 
research: 1) Visual appearance, 2) Friability 3) Disintegration 4) Taste 5) packaging 6) 
Embossing 7) Hardness . The human Resource factors included in this paper were 1) 
willingness to change 2) Knowledge 3) Skill 4) Commitment 5) Attitude 6) Teamwork 
and 7) leadership. Analytical Hierarchy Process was undertaken to facilitate ranking 
procedures. The subsequent ranking for product quality was 1) Strip Packing 2) uneven 
color, 3) Visual appearance 4) Friability 5) Texture 6) Blister Packing 7) Disintegration 
8) Taste 9) Crack 10) Packaging 11) shape 12) Embossing and 13) Hardness Th final 
ranking of the human resources factors was 1) Willingness to Change 2) Knowledge 3) 
Skill 4) Commitment 5) Attitude 6) Teamwork and 7) Leadership. 
It was found that it was vital for process Engineers to consider the identified 
factors and accord them with fundamental importance in establishing high quality 
process function. Participation and input from Human resources was also gauged as 
important factor in determining High Quality. HR participation is the transformation of 
personnel as vital ingredients in successful output. 
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CHAPTER ONE 
INTRODUCTION 
1.0 Introduction 
A new millennium, it is very obvious that the general population has 
become highly aware of the whole concept of "Quality of Life" of special 
concern is the quality life available in the country. The reference to quality 
life involves general health, the work environment, food consumed, and 
others that are essential to developing and establishing styles. Most people 
are always want quality of the products they take to keep a good life style. A 
good indicator of this would be the introduction of numerous healthcare 
products into the Malaysian markets. The consumption of these product has 
been positively correlated with an increase in the life span from 70 years to 
80 years. (Source: Department of Statistics, Malaysia) 
1.1 Pharmaceutical Market 
From this point of view Quality of Life is also highly linked with the 
economy of the country. The Malaysian economy is a stable one. It is 
expected to remain stable with the Barisan Nasional Government providing 
the necessary economic incentives for the development of self-sufficient local 
industries. This is in keeping with the Seventh Malaysia Plan. This is in line 
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with the strategic objective of developing the country into a major export 
player, as well as in efforts to reduce imports so as to balance out the trade 
deficits, which the country presently faces. 
The Malaysian Economy is still expected to register an 8.5% growth 
for the year 1997 and is forecasted to continue at 8% over the marketing plan 
period. This is owed to the numerous mega construction and development 
projects which have been initiated over 1995 and 1996. 
With an growing economy we have a nationally growing market of 
this constitutes the pharmaceutical market at present stands at is one billion 
Malaysian Ringgit, 40 % of it supplied by local manufactured 
pharmaceuticals. 
Figure 1 , showed a forecast of Malaysian local pharmaceutical 
market trend. It is believed that current 40 % market share would be 
increased up to 47 %. Various effort have been done to ensure this forecast 
become a reality. One of its or suggested by this project is using quality 
System. 
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Figure 1: Market Trend till Year 2003 
The above figure from IMS Report 1996 which say that 60 % is 
imported pharmaceuticals, which means that 40 % contributes to local 
manufactured pharmaceuticals. This was confirmed from observations in 
the market, sales report and forecast of the market that is available. 
The balance of 60 % of the National Pharmaceutical requirement is 
dominated by Multinational corporations. They have achieve this through 
professional and aggressive marketing strategies with the support of by 
their parent company. 
Most of these pharmaceuticals are imported with only a handful of 
them being manufactured locally. Although there are some 56 registered 
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local manufacturers of pharmaceuticals in the country, less than five have 
had any significant impact on the industry, by way of reputation of quality 
and market shares. May be if the majority of them are small producers, 
producing small range of lower level products. This manufacturers have 
little or ineffective marketing. Realizing their weakness, many small 
manufacturers are now try to consolidate among them. Especially with the 
facilitation by Malaysia corporate giants who are keen of diversifying their 
business and venture to health sector. 
1.2 Quality 
Several individuals have strongly influenced companies in both 
manufacturing and services sectors to emphasize quality. Initially, their 
ideas found greater acceptance in Japan than in the United States. 
There are three gurus or experts in quality . 
• :. W. Edwards Deming, considered to be the father of quality control in 
Japan, summarized the far reaching, long lasting effects of improving 
quality with his five steps chain reaction: 
.:. First, cost declines because of less rework, fever mistakes, fewer 
delays and better use of time and materials, which 
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.:. Result in improved productivity, which 
.:. Increases market share because of better quality and prices, which 
.:. Increase profitability, allowing the company to stay in business, 
which 
.:. Results in more jobs. 
The central concern of 'Quality' is its very definition in Table 1:1 
shows some of the functional definition proposed. Joseph M. Juran (1989), 
stressed that quality is "fitness for use". This implies that the products on 
consumption, must be successfully beneficial to the user meets their needs 
and satisfaction. Juran explained that quality has a dual meaning; product 
features that meet those customers needs and a product free from 
deficiencies 
Table 1:1 Definition of quality 
PRODUCT FEATURES THAT FREEDOM FROM DEFICIENCIES 
MEETS CUSTOMERS NEEDS 
Higher quality enables companies to : Higher quality enables companies to: 
.:. Increase product saleable .:. Reduce error work 
.:. Meet Competition .:. Reduce rework, waste 
. :. Increase market share .: . Reduce customers dissatisfaction 
. :. Provide sales income .: . Reduce inspection, test 
.:. Secure premium price .:. Increase yield, capital 
Source: Joseph M. Juran, Juran on Leadership for Quality,1989 
5 
According to Kivenko (1984), there is five common definition of 
quality: a) relative excellence, b) value for money, c) conformance to 
drawings, d) conformance to the purchase order and e) fitness for intended 
function. Relative excellence means the product can give what the customers 
actually want (the satisfaction) so that they are interested to continue buying 
the product from the same companies or manufacturer. Conformance to 
drawings and specification are certainly one of the best way of measuring 
the quality of the product. If the drawings and specifications of the prod�ct 
are clear, it is adequate to provide all things that the users expect. The 
concept practice in conformance to purchase order. Fitness for intended 
function means that the product being what it is supposed to be and doing 
what it is supposed to do. 
1.2.1 The Need for Quality 
The need for quality in the manufacturing sector is obvious. This is 
more prominently seen, in the pharmaceutical-manufacturing sector, the 
strongest competitor will get all the business because they deliver quality 
product that performs to customer satisfaction. Not only this deal with 
human life, nevertheless failure in quality exposes the manufacturers to 
legal issue. Quality is also a moral issue. If the customer finds that a product 
doesn't conform to a certain specifications, its will ruin the business 
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enterprise. Companies will then not be able to survive in a growth market 
without a working quality system in place. 
Since quality of pharmaceutical products are always affecting the 
human health, therefore quality should always be the deciding factor in the 
purchase of the product, not the price. Continuous and consistent product 
consumption by consumer can only be maintained if the product contains 
quality or as requirement by standa.:."ds of that drug . .  There is apparently a 
need for quality in the design of products. Poorly designed product never 
will reach sufficient level of quality to meet customer needs. No matter how 
hard the manufacturing organisation tries, that marketing effort or other 
means consumption and demand for a product will ultimately rest on its 
quality and design. 
In pharmaceutical product quality must start from research and 
development design, production and with people marketing 
pharmaceutical, it will be able to sustain in the market place. Therefore it is 
not a one quality assurance department responsibility. It involves many 
complex areas in the life of a product. Furthermore it is important that 
manufacturer must take a specific steps to improve the quality of product in 
every stage of the production line. 
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Commitment to quality in a company requires a systems approach. It 
requires the participation from all managers, workers and every person who 
are involved in the production process. This is the only approach, that 
secures the manufacturer of quality goals, of high quality products and 
assurance of meeting the customer needs and satisfaction. 
As most of the manufacturing sector had some form of quality 
. .:ontrol system to assure that the market received. goods of some defined 
standards set by the government of Malaysia. In the case of pharmaceutical, 
the criteria for quality were more stringent; the controlling body was Drug 
Control Authority of Malaysia of the Ministry of Health. Which follows 
the British Pharmacopoeia or the Russia Pharmacopoeia standards. 
The Malaysian Ministry of Health was one of the important primary 
sources of control to all pharmaceuticals in Malaysia. This needs much 
documentation to be full filled before the drug is released into the market. It 
provides documentation in the form of several certificates, which are 
mandatory by the health authorities locally, and oversea market. 
The export of pharmaceuticals from Malaysian manufacturers to 
destination abroad in 1996 amounted to less than 0.5% of the country's gross 
exports of manufactured goods. Nevertheless, with the government's call 
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for Malaysian manufacturers to aggressively consider the export potential to 
boost the country's earnings, the local pharmaceutical industry should be 
encouraged to rise to this call and not be contented to limit their operations 
to the domestic sector alone. 
The purpose of this paper is to provide some insights into how one 
may proceed with obtaining the relevant information prior to exporting 
their products overseas. This needs quality to be maintained. 
Some of the primary documentation required as a precondition of 
consideration by parties overseas might be obtained from the Malaysian 
authorities, some of which are briefly mentioned in the following 
paragraphs: 
1.2.2 Malaysian Drug Control Authority of the Ministry of Health 
The Malaysian Ministry of Health is one of the important primary 
sources of documentation. It provides documentation in the form of 
several certificates, which are mandatory, required by the 
corresponding health authorities in the importing countries as a 
quality control guideline for the products. 
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i. Product Registration CertificatejProduct License 
This certificate is one, which is issued by the Drug Control Authority 
upon the registration of a manufactured product. Products, which 
fulfil the requirements of product registration under the Control of 
Food and Drugs Act, 1954 are granted a product, license. Implied in 
such granting of license is the fact that the authorities are satisfied 
that the products have met the quality, efficacy and safety 
considerations warranting approval. 
Product Registration Certificates or Product licenses are a basic 
requirement of the authorities abroad as they serve to confirm that a 
particular pharmaceutical preparation has met the basic requirements 
as previously mentioned, for it to be on the local market. However, 
not all countries insist on having this certificate as compared to the 
Free Sales Certificate. 
ii. Certificate of Free Sales in Malaysia 
This certificate confirms that the product registered is freely sold in 
the country of manufacture. Hence, most authorities accept the Free 
Sales Certificate in lieu of the product license. 
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